Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-09-29
1986-01-28
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
045671850
ABSTRACT:
A method of permitting restful sleep at high altitudes is disclosed involving administration to a patient susceptible to Cheyne-Stokes respiration of a pharmaceutically acceptable amount of an endorphin-blocking compound capable of blocking the action of endogenous endorphins, whereby sleep interruptions characteristic of Cheyne-Stokes respiration are alleviated. There is also disclosed a method of permitting a continuous flow of oxygen to the brain cells in a sleeping patient otherwise susceptible to repeated interruptions of breathing that would retard the necessary steady flow of oxygen to brain cells to maintain their viable condition, which comprises administration prior to retiring of a pharmaceutically acceptable amount of an endorphin-blocking compound capable of blocking the action of endogenous endorphins to substantially obviate sleep interruptions that otherwise would occur. In a different embodiment there is provided a method of retarding the advance of the symptoms of senility in a patient having a gross loss of effective sleep and an erosion of viable brain cells due to the periodic disruption of sleep including periods of total lack of breathing depriving the brain of a necessary minimum oxygen level to sustain healthy brain tissue, said periodic disruption taking place during periods of sleep due to periodic cessation of breathing, said method comprising administering to said patient a chemical agent that blocks periodic cessation of breathing to maintain the necessary minimum oxygen level to sustain healthy brain tissue during periods of sleep.
Also provided is a method of retarding the symptoms of aging caused by a decreased level of oxygen in the bloodstream in a geriatric patient which promotes excessive endorphin levels, by administering to a geriatric patient with diminished oxygen circulation in the bloodstream an endorphin blocker, whereby the normal level of endorphin is restored, thereby obviating the effects of the excess endorphin.
REFERENCES:
patent: 4454142 (1984-06-01), Tuttle
Chem. Abst. 93-179633d, (1980), 95-126220b, (1981), .sym. 97-66289k, (1982).
Friedman Stanley J.
Key Pharmaceuticals, Inc.
Meloy Sybil
LandOfFree
Endorphin blockage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endorphin blockage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endorphin blockage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1306466